KCNK3 and neoplasm: In the 508 primary LUAD tissues and 59 normal samples originated from the Cancer Genome Atlas (TCGA), we found that KCNK3 was significantly downregulated in different clinical stages of LUAD tissues compared with non-tumor tissues, especially in stage I LUAD patients (Fig. 1A).